Z-IETD-FMK

Catalog No.S7314 Batch:S731402

Print

Technical Data

Formula

C30H43FN4O11
Molecular Weight 654.68 CAS No. 210344-98-2
Solubility (25°C)* In vitro DMSO 100 mg/mL (152.74 mM)
Water Insoluble
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO Corn oil
2.25mg/ml Taking the 1 mL working solution as an example, add 50 μL of 45 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Z-IETD-FMK (Caspase-8 Inhibitor, Z-IE(OMe)TD(OMe)-FMK) is a specific Caspase-8 inhibitor. Z-IETD-FMK is also an inhibitor of granzyme B.
Targets
Caspase-8 [1]
In vitro

Z-IETD-FMK, which inhibits the cleavage of caspase-8 and partially inhibits the cleavage of caspase-3 and PARP, prevents the execution of apoptosis in retinal cells exposed to different apoptotic stimuli. [1]

Z-IETD-FMK (50 μM) reduces ceramide-induced cardiomyocyte death and significantly inhibits the activation of caspase 3. [2]

Inhibition of caspase-8 by Z-IETD-FMK affects the generation of activated/memory T cells and T cell cytokine production, and decreases NF-kappaB responses to TCR:CD3 engagement in T cell cultures. [3]
In vivo

In vivo, inhibition of caspase-8 by Z-IETD-FMK reduces memory/activated CD4 and CD8 T cells, and increases susceptibility to T. cruzi infection. [3]

Z-IETD-FMK promotes neuronal survival and regeneration of injured retinal ganglion cells after CNS injuries. [4]

Protocol (from reference)

Cell Assay:

[2]
  • Cell lines

    Rat neonatal cardiomyocytes

  • Concentrations

    50 µM

  • Incubation Time

    24 h

  • Method

    Drugs were added to the cell culture medium simultaneously with ceramide, and surviving cells were counted 24 hours later.
Animal Study:

[3]
  • Animal Models

    T. cruzi-infected mice

  • Dosages

    0.4 mg/3 days

  • Administration

    --

Customer Product Validation

Data from [Data independently produced by , , Cell Physiol Biochem, 2017, 42(5):1822-1836]

Data from [Data independently produced by , , Int J Oncol, 2018, 52(3):1023-1032]

Data from [Data independently produced by , , Drug Des Devel Ther, 2017, 11:2841-2850]

Data from [Data independently produced by , , PLoS One, 2017, 12(2):e0171840]

Selleck's Z-IETD-FMK has been cited by 65 publications

EFHD2 suppresses intestinal inflammation by blocking intestinal epithelial cell TNFR1 internalization and cell death [ Nat Commun, 2024, 15(1):1282] PubMed: 38346956
ERK mediates interferon gamma-induced melanoma cell death [ Mol Cancer, 2023, 10.1186/s12943-023-01868-x] PubMed: 37803324
THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic β-cell function and preserving β-cell mass [ Nat Commun, 2023, 14(1):1020] PubMed: 36823211
Caspase-8 inhibition improves the outcome of bacterial infections in mice by promoting neutrophil activation [ Cell Rep Med, 2023, 4(7):101098] PubMed: 37390829
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding [ SCIENCE ADVANCES, 2023, Vol-9,-Issue-12] PubMed: None
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding [ SCIENCE ADVANCES, 2023, Vol-9,-Issue-12] PubMed: None
ER stress induces caspase-2-tBID-GSDME-dependent cell death in neurons lytically infected with herpes simplex virus type 2 [ EMBO J, 2023, e113118.] PubMed: 37646198
Uptake-independent killing of macrophages by extracellular Mycobacterium tuberculosis aggregates [ EMBO J, 2023, e113490.] PubMed: 36920246
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma [ Cancer Sci, 2023, 114(3):1095-1107] PubMed: 36369966
AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME-conferred pyroptosis in non-small cell lung cancer [ J Cell Mol Med, 2023, 27(16):2412-2423] PubMed: 37438979

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.